Literature DB >> 16515405

Clinical genomics data standards for pharmacogenetics and pharmacogenomics.

Amnon Shabo1.   

Abstract

This special report concerns a talk on data standards given at a workshop entitled 'An International Perspective on Pharmacogenetics: The Intersections between Innovation, Regulation and Health Delivery', which was held by the Organization for Economic Co-operation and Development (OECD) on October 17-19, 2005, in Rome, Italy. The worlds of healthcare and life sciences (HCLS) are extremely fragmented in terms of their underlying information technology, making it difficult to semantically exchange information between disparate entities. While we have reached the point where functional interoperability is ubiquitous, we are still far from achieving true semantic interoperability where a receiving system can use incoming data as though it was created internally. The critical enablers of semantic interoperability are information standards dedicated to HCLS data, spanning all the way from biological research data to clinical research and clinical trials, and finally to healthcare clinical data. The challenge lies in integrating various data standards based on predetermined goals, thereby improving the quality of care provided to patients.

Entities:  

Mesh:

Year:  2006        PMID: 16515405     DOI: 10.2217/14622416.7.2.247

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  6 in total

1.  Genetic tests and genomic biomarkers: regulation, qualification and validation.

Authors:  Giuseppe Novelli; Cinzia Ciccacci; Paola Borgiani; Marisa Papaluca Amati; Eric Abadie
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

2.  Integrating pharmacogenomics into the electronic health record by implementing genomic indicators.

Authors:  Pedro J Caraballo; Joseph A Sutton; Jyothsna Giri; Jessica A Wright; Wayne T Nicholson; Iftikhar J Kullo; Mark A Parkulo; Suzette J Bielinski; Ann M Moyer
Journal:  J Am Med Inform Assoc       Date:  2020-01-01       Impact factor: 4.497

3.  Towards interoperable reporting standards for omics data: hopes and hurdles.

Authors:  Susanna-Assunta Sansone; Philippe Rocca-Serra; Dawn Field; Chris F Taylor; Weida Tong; Marco Brandizi; Eamonn Maguire; Nataliya Sklyar
Journal:  Summit Transl Bioinform       Date:  2009-03-01

4.  Incorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 1: an overview of requirements.

Authors:  Timur Beyan; Yeşim Aydın Son
Journal:  JMIR Med Inform       Date:  2014-07-24

5.  A national clinical decision support infrastructure to enable the widespread and consistent practice of genomic and personalized medicine.

Authors:  Kensaku Kawamoto; David F Lobach; Huntington F Willard; Geoffrey S Ginsburg
Journal:  BMC Med Inform Decis Mak       Date:  2009-03-23       Impact factor: 2.796

Review 6.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.